These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 24182219)
81. Downstaging is more important than screening for asymptomatic breast cancer. Yip CH Lancet Glob Health; 2019 Jun; 7(6):e690-e691. PubMed ID: 31097267 [No Abstract] [Full Text] [Related]
82. The elusive diagnosis of cancer: testing times. Nicholson BD; Perera R; Thompson MJ Br J Gen Pract; 2018 Nov; 68(676):510-511. PubMed ID: 30361301 [No Abstract] [Full Text] [Related]
83. Response to Lehrer and Rheinstein. Fedewa SA; Ma J; Jemal A J Natl Cancer Inst; 2020 Oct; 112(10):1069-1070. PubMed ID: 32602890 [No Abstract] [Full Text] [Related]
86. Antibiotic resistance and transrectal prostate biopsies. Davies RJ; Stephenson BM; Llewelyn M; Carter AC; Kubiak E BMJ; 2013 Feb; 346():f1171. PubMed ID: 23444435 [No Abstract] [Full Text] [Related]
87. Prostate cancer screening and the management of clinically localized disease. Wilt TJ; Ahmed HU BMJ; 2013 Jan; 346():f325. PubMed ID: 23360718 [No Abstract] [Full Text] [Related]
88. [Prostate cancer screening]. RodrÃguez-Carlin A; Castillo O Medwave; 2016 Jul; 16(6):e6504. PubMed ID: 27532121 [No Abstract] [Full Text] [Related]
89. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role? Jackson BR Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565 [No Abstract] [Full Text] [Related]
90. Prostate cancer screening. Faigen M Med J Aust; 2013 Nov; 199(9):585. PubMed ID: 24182219 [No Abstract] [Full Text] [Related]